Epizyme - Articles and news items

Epizyme releases additional data from Phase 1 study of tazemetostat in non-Hodgkin’s lymphoma

Industry news / 22 June 2015 / Victoria White

Epizyme has reported results from the ongoing Phase 1 trial of tazemetostat in patients with advanced B-cell non-Hodgkin’s lymphoma and solid tumours…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+